oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2019 ( 116 )

2018 ( 190 )

2017 ( 210 )

2016 ( 265 )

Custom range...

Search Results: 1 - 10 of 146058 matches for " F.; Garrido-Garrido "
All listed articles are free for downloading (OA Articles)
Page 1 /146058
Display every page Item
Introducción de la suplementación con formulaciones Vimang en el síndrome doloroso regional complejo: experiencia en 15 pacientes Introduction of supplementation with Vimang formulations in complex regional pain syndrome: Experience in 15 patients
B. Garrido-Suárez,M.C. Rabí,F. Bosch,G. Garrido-Garrido
Revista de la Sociedad Espa?ola del Dolor , 2009,
Abstract: Introducción: En la actualidad el estrés oxidativo, la neuroinflamación y la activación glial han adquirido relevancia en la fisiopatología del síndrome doloroso regional complejo (SDRC), de ahí que la terapia con agentes antioxidantes e inhibidores de la producción de citocinas proinflamatorias ha comenzado a ensayarse. El Vimang es una marca comercial registrada que cubre varios tipos de formulaciones a partir del extracto de la corteza del árbol de mango con efecto inhibidor de la activación del factor de transcripción nuclear kB (NFkB), promotor de la expresión de mediadores y sistemas enzimáticos involucrados en la inflamación y el dolor, el estrés oxidativo y la plasticidad sináptica. Objetivo: El propósito del presente estudio fue determinar la actividad analgésica de la suplementación con formulaciones Vimang en 15 pacientes con SDRC y la posible mejoría de la capacidad funcional postratamiento. Material y métodos: Los pacientes recibieron Vimang tabletas 1.800 mg/día/8 h, crema 1,2% en el miembro afectado 3 veces/día y un bloqueo simpático semanal durante 4 meses. Se introdujo la fisioterapia al mes. Las variables evaluadas fueron las puntuaciones diarias medias de dolor (PDMD) mediante una escala de Likert, el área e intensidad de la alodinia mecánica dinámica, la alodinia al frío, somática profunda y la frecuencia del dolor paroxístico. Se aplicó la escala de Enneking et al. modificada para evaluar la funcionabilidad articular. Resultados: Las PDMD y el resto de las alteraciones sensoriales se redujeron significativamente desde la semana 2 a 3 de iniciado el tratamiento respecto a los valores iniciales. La funcionabilidad del miembro afectado aumentó de un promedio de 22,7 a 78,7%. Estas formulaciones pudieran introducirse en el tratamiento del SDRC, pero es necesario sistematizar los estudios. Introduction: Currently, oxidative stress, neuroinflammation and glial activation are accepted as playing a pathophysiological role in complex regional pain syndrome (CRPS) and consequently antioxidant agents and proinfl ammatory cytokine inhibitors have begun to be assessed in the treatment of this disorder. Vimang is a new phytodrug prepared from the stem bark of Mangifera indica L., registered in Cuba with inhibitory effect on nuclear transcription factor kB (NFkB), which induces expression of some mediators and enzymes involved in inflammation, oxidative stress, pain, and synaptic plasticity. Objective: To determine the analgesic effects of Vimang tablets and 1.2% cream as a topical agent in 15 patients with CRPS, as well as possible improvemen
Utilidad del Extracto de Mangifera Indica L (VIMANG) en el Síndrome Doloroso Regional Complejo: A propósito de un caso Usefulness of Mangifera Indica L (Vimang ) in the treatment of Complex Regional Pain Syndrome (CRPS): A case report
B. Garrido-Suárez,F. Bosch,G. Garrido-Garrido,R. Delgado-Hernández
Revista de la Sociedad Espa?ola del Dolor , 2007,
Abstract: Los avances en el conocimiento actual de la fisiopatología del Síndrome Doloroso Regional Complejo (SDRC), conducen a la búsqueda de nuevos fármacos dirigidos a los blancos moleculares que se involucran en sus complejos mecanismos. En la actualidad se considera el papel activo de la neuroinflamación en el fenómeno de hiperexcitabilidad del cuerno dorsal espinal y el establecimiento de la sensibilización central dentro de sus procesos subyacentes. El Extracto obtenido de la corteza de variedades seleccionadas de la especie Mangifera indica L. y que se comercializa en Cuba bajo la Marca Registrada VIMANG , posee actividad antioxidante, antiinflamatoria y antihiperalgésica in vivo. Por otra parte estudios in vitro demostraron su efecto inhibidor sobre múltiples moléculas que participan en la cascada de la sensibilización central y en un modelo de isquemia-reperfusión sus cualidades neuroprotectoras. Presentamos el caso de una paciente con diagnóstico de SDRC tipo II, secundario a una lesión del plexo braquial, con sección del nervio radial a nivel humeral que fue provocada por el desplazamiento de la fractura del húmero izquierdo. La paciente llega a nuestro servicio a los 4 meses de evolución, con síntomas sensoriales, dolor persistente quemante y paroxístico, alodinia mecánica, edema, cambios vasomotores hacia la hiperhemia y mano en flexión por pérdida de la función motora de los músculos extensores del antebrazo. Con compromiso de la articulación del carpo y hombro de limitación severa y dolor de valor 5 en una escala numérica de Likert. El estudio de conducción nerviosa mostró alteraciones mielínico-axonales discretas del nervio mediano y mielínico-axonales severas del nervio radial. Se instauró el tratamiento con Vimang (300mg) 2 tabletas cada 8 horas por 4 meses y la aplicación local de la crema Vimang 3 veces al día, asociado a los bloqueos simpáticos y somáticos para miembro superior y a la fisioterapia. La evolución clínica y electrofisiológica fue muy favorable. Este caso constituye el primero descrito en la literatura, en el cual se introduce este producto a la terapia múltiple del síndrome, se deben dirigir los estudios básicos y clínicos en este sentido, dadas las posibilidades terapéuticas del Vimang en el SDRC. Advances in our understanding of Complex Regional Pain Syndrome (CRPS) physiopathology have led to new drugs targeted toward molecular mediators involved in the complex mechanisms of pain. Neuroinflammation is thought to have an active role in phenomena underlying spinal cord dorsal horn hyperexcitability and the establishment of cen
Introducción de la suplementación con formulaciones Vimang? en el síndrome doloroso regional complejo: experiencia en 15 pacientes
Garrido-Suárez,B.; Rabí,M.C.; Bosch,F.; Garrido-Garrido,G.; Delgado-Hernández,R.;
Revista de la Sociedad Espa?ola del Dolor , 2009,
Abstract: introduction: currently, oxidative stress, neuroinflammation and glial activation are accepted as playing a pathophysiological role in complex regional pain syndrome (crps) and consequently antioxidant agents and proinfl ammatory cytokine inhibitors have begun to be assessed in the treatment of this disorder. vimang? is a new phytodrug prepared from the stem bark of mangifera indica l., registered in cuba with inhibitory effect on nuclear transcription factor kb (nfkb), which induces expression of some mediators and enzymes involved in inflammation, oxidative stress, pain, and synaptic plasticity. objective: to determine the analgesic effects of vimang? tablets and 1.2% cream as a topical agent in 15 patients with crps, as well as possible improvement in post-treatment functional capacity. material and methods: the patients received a daily dose of 1800 mg of vimang? tablets for 120 days, 1.2% cream in the affected limb 3 times/day, and sympathetic blocks once a week for 4 months. physiotherapy was introduced after 30 days. the variables evaluated were changes in average daily pain score through a likert scale, the area and rate of dynamic mechanical allodynia, rate of cold allodynia, deep somatic allodynia and frequency of burning spontaneous pain. a modified scale of enneking et al. was applied to evaluate functional capacity. results: the average daily pain score and sensory abnormalities significantly improved from week 2-3. on average, the functional capacity of the affected limb increased from 22.7 % to 78.7%. our results suggest that vimang? formulations might be useful in crps treatment. however, further studies are required.
Utilidad del Extracto de Mangifera Indica L (VIMANG) en el Síndrome Doloroso Regional Complejo: A propósito de un caso
Garrido-Suárez,B.; Bosch,F.; Garrido-Garrido,G.; Delgado-Hernández,R.; Porro,J. N.; Manero,J. M.;
Revista de la Sociedad Espa?ola del Dolor , 2007,
Abstract: advances in our understanding of complex regional pain syndrome (crps) physiopathology have led to new drugs targeted toward molecular mediators involved in the complex mechanisms of pain. neuroinflammation is thought to have an active role in phenomena underlying spinal cord dorsal horn hyperexcitability and the establishment of central sensitivity. an extract from the bark of selected mangifera indica l species, registered under the vimang? trade mark in cuba, has antioxidant, anti-inflammatory and antihyperanalgesic activity in vivo. in vitro studies have demonstrated that it has an inhibitory effect on several molecules mediating the central sensitization cascade and an ischemic-reperfusion model has proved its cerebral neuroprotective qualities. we present a patient with type ii crps secondary to a brachial plexus lesión following a displaced left humerus fracture that sectioned the radius nerve. the patient presented in our pain clinic four months after the accident with sensorial symptoms, persistent burning pain mechanical allodynia, oedema, vasomotor alterations tending to hyperhaemia and a flexed hand due to loss of the motor function in the fore arm extensors. carpal and shoulder joint movement was severely limited and she scored 5 on the likert pain scale. electrophysiological study revealed mild myelin-axonal alterations in the median nerve and severe alterations in the radial nerve. treatment with vimang (300 mg; 2 tablets/8 hours/4 months) with topical administration of vimang cream 3 times per day combined with sympathetic and somatic nerve blocks in the upper limb and physiotherapy were begun. the patient's clinical and electrophysiological evolution was very favourable. this is the first description of the use of this product in combined crps therapy. our results indicate that further basic and clinical research into the use of vimang? for crps is justified.
Ingeniería tisular y medicina regenerativa en cirugía pediátrica Tissue engineering and regenerative medicine in pediatric surgery
Matías Garrido F
Revista Chilena de Cirugía , 2011,
Abstract:
Ochthebius (Calobius) quadricollis Mulsant, 1844 en la costa atlántica del noroeste de Espa a (Coleoptera, Hydraenidae)
Garrido, J.,Valladares, L. F.
Graellsia , 2001,
Abstract: Not available No disponible
Chaotic principle: an experimental test
F. Bonetto,G. Gallavotti,P. L. Garrido
Physics , 1996, DOI: 10.1016/S0167-2789(97)00007-9
Abstract: The chaotic hypothesis discussed in [GC1] is tested experimentally in a simple conduction model. Besides a confirmation of the hypothesis predictions the results suggest the validity of the hypothesis in the much wider context in which, as the forcing strength grows, the attractor ceases to be an Anosov system and becomes an Axiom A attractor. A first test of the new predictions is also attempted.
Continuum Field Description of Driven Lattice Gases
F. de los Santos,P. L. Garrido
Physics , 1998, DOI: 10.1023/A:1004580618162
Abstract: We review the critical behaviour of the Driven Lattice Gas (DLG) model. As a result, we obtain a novel Langevin equation for the DLG which depends on the microscopic transition probabilities. We then show how this dependence affects the critical behaviour of the the DLG placing the finite and the infinite driving field cases into different universality classes. Two other well known anisotropic, conservative, non-equilibrium models, the two-temperature model and the randomly driven model (RDLG) are also studied. It is shown that the RDLG with infinite averaged field and the two-temperature model with infinite parallel temperature fall in the same universality class as the infinitely driven DLG. A Langevin equation for the two-layer DLG is also presented.
Modelos animales de dolor y electroacupuntura
Garrido,B.; Bosch,F.; Garrido,G.; Hernández-Balmaseda,I.; Delgado-Hernández,R.;
Revista de la Sociedad Espa?ola del Dolor , 2007,
Abstract: animal models of pain have permitted in the last decades important advances in neurobiologic research, but biological systems are not exact and there are múltiple factors that can lead to contradictory results. those difficulties are exacerbated in models addressed to electroacupuncture treatment procedures, as a parametric variability exists for the liberation of mediators, also for the response of biochemical systems manipulated under physiologic or pathological conditions, among other the influence of the stress induced analgesia (sia). our purpose is to critically analyze some recent experiments in this field, from authors that have faced these difficulties and still have provided important elements for the clarification of the mechanisms involved in acupuncture analgesia.
Libros
Garrido, A.,Hidalgo, F. J.,Garrido Fernández, A.,Durán Quintana, María C.
Grasas y Aceites , 1992,
Abstract:
Page 1 /146058
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.